Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8753757 | 0.95 | L3MBTL1 (0.56) | L3MBTL1TDP1GRM2PTPN1MCHR1 | |
| SCHEMBL30625031 | 0.95 | L3MBTL1 (0.56) | L3MBTL1TDP1GRM2PTPN1MCHR1 | |
| SCHEMBL2511831 | 0.93 | L3MBTL1 (0.54) | L3MBTL1TDP1GRM2PTPN1MCHR1 | |
| SCHEMBL4826935 | 0.93 | L3MBTL1 (0.54) | L3MBTL1TDP1GRM2PTPN1MCHR1 | |
| SCHEMBL8746459 | 0.93 | L3MBTL1 (0.54) | L3MBTL1TDP1GRM2PTPN1MCHR1 | |
| SCHEMBL8234319 | 0.93 | L3MBTL1 (0.54) | L3MBTL1TDP1GRM2PTPN1MCHR1 | |
| SCHEMBL7781687 | 0.93 | L3MBTL1 (0.54) | L3MBTL1TDP1GRM2PTPN1MCHR1 | |
| SCHEMBL8746453 | 0.93 | L3MBTL1 (0.54) | L3MBTL1TDP1GRM2PTPN1MCHR1 | |
| SCHEMBL427889 | 0.90 | L3MBTL1 (0.53) | L3MBTL1TDP1GRM2MCHR1CYP1A2 | |
| SCHEMBL8216509 | 0.84 | L3MBTL1 (0.50) | L3MBTL1TDP1GRM2MCHR1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7083832-B2 | Partially fluorinated liquid crystal material | DISPLAYTECH, INC. (US) | 2006-08-01 | — | — | US | disclosed |
| US-20030017278-A1 | Partially fluorinated liquid crystal material | CITIZEN FINETECH MIYOTA CO., LTD. (JP) | 2003-01-23 | — | — | US | disclosed |
| WO-2002018514-A1 | PARTIALLY FLUORINATED LIQUID CRYSTAL MATERIAL | DISPLAYTECH, INC. (US) | 2002-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030017278-A1 | Partially fluorinated liquid crystal material | LEF1, SETDB1, INF2 | L3MBTL1 425/4885TDP1 2156/4885GRM2 3287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.